Otsuka : Chemical Announces Personnel Changes (187KB)
March 11, 2020 at 02:26 am EDT
Share
Ma rc h 11, 2020
Otsuka Chemical Announces Personnel Changes
Otsuka Chemical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd., announced the changes of directors. The change was ratified today at the annual general shareholders' meeting and a
meeting of its Board of Directors.
Changes of Directors
Name
Takeharu Harashima
New Position
Chairman, Otsuka Chemical Co., Ltd.
Previous Position
President and Representative Director, Otsuka Chemical Co., Ltd.
Effective Date
March 11, 2020
Name
Hiroyoshi Tosa
New Position
President and Representative Director, Otsuka Chemical Co., Ltd.
Previous Position
Member of the Board, Otsuka Chemical Co., Ltd.
Effective Date
March 11, 2020
Attachments
Original document
Permalink
Disclaimer
Otsuka Holdings Co. Ltd. published this content on 11 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2020 06:25:02 UTC
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),